Latest news with #DEGRESINX
Int'l Business Times
3 days ago
- Business
- Int'l Business Times
BIO INX: Bridging the Gap Between Regenerative Research and Real-World Impact
Decades of scientific discovery in tissue engineering and regenerative medicine have led to breakthroughs. However, the translation of these technologies into clinical therapies hasn't been as immediate as anticipated. BIO INX was founded to address this bottleneck. Its mission is to equip scientists, clinicians, and industry players with the reliable biomaterials they need to bring 3D bio-printing closer to everyday healthcare. BIO INX's co-founder and CEO, Jasper Van Hoorick, was driven by the belief that materials science could be the key to solving challenges in regenerative medicine. His background in polymer chemistry and a PhD focused on corneal regeneration opened his eyes to a repeating pattern in academic research. BIO INX's co-founder and CEO, Jasper Van Hoorick "Promising materials and prototypes would be developed, never further than academic publications, only to be shelved when the original researchers move on," Van Hoorick shares. Indeed, progress stalls without a reproducible and standardized pipeline for translating these materials into clinical-grade tools. Instead of waiting for innovation to make its way out of the lab, Van Hoorick decided to take action. Throughout the final stages of his PhD, Van Hoorick started planning BIO INX in earnest. He wrote grant proposals between thesis chapters, secured initial funding, and built a team that began maturing the company's first products while still operating within the academic environment. By the time the company officially spun out, it had already established partnerships and was positioned to take its materials beyond the proof-of-concept phase. Now, BIO INX is known for developing and offering high-performance, ready-to-use biomaterials for 3D bioprinting and biofabrication. These materials are crafted with reproducibility, scalability, and compatibility with multiple printing technologies in mind. The company has a diverse and adaptable product portfolio that supports various biomedical applications, from tissue regeneration to pharmaceutical screening. One of BIO INX's unique strengths is its multidisciplinary foundation. Its team, with over two decades of experience in polymer science, bioengineering, and printing technologies, combines academic expertise with an applied mindset. This enables the company to create materials tailored for specific biological purposes and ensure that those materials meet the technical demands of modern bioprinting platforms. Essentially, with solutions that span different material properties, resolution scales, and printing modalities, BIO INX helps remove the technical obstacles that typically delay or derail regenerative projects. A 3D printed scaffold to guide cell growth made out of DEGRES INX, a biodegradable polyester based resin The Belgium-based company is proud to share that it has been involved in several proof-of-concept projects that illustrate the clinical and scientific potential of its materials. One of them is the Astrocardia, a heart-on-a-chip experiment. The project has focused on modeling cardiovascular aging, a process that naturally takes decades but is dramatically accelerated in space. By bioprinting miniature cardiac tissues using a novel bioink, BIO INX has contributed to the development of human-derived aging models. These models may eventually support personalized therapies and more predictive drug screening approaches, both on Earth and in space. BIO INX has also participated in a project on ocular regeneration. Drawing from Van Hoorick's doctoral work on corneal tissue, the company has been tackling the shortage of viable donor tissue for corneal transplants. "Current treatments rely on corneas from human donors, but the supply is insufficient," Van Hoorick says. BIO INX has been working in collaboration with a clinical partner to develop bioinks that allow for the regeneration of corneal tissue without the need for invasive surgery. Because the eye is uniquely accessible and allows for direct visual monitoring, it presents a promising target for regenerative strategies. The potential to restore vision with personalized, cell-based therapies could represent a meaningful advancement for patients facing corneal blindness. A third area that has been in development is cartilage and bone regeneration. The InCart-3D initiative has explored how digital light processing (DLP) bioprinting can be combined with next-generation bioinks to rebuild complex skeletal tissues. Treating the cartilage is challenging because it lacks the natural ability to heal. By creating structurally accurate, cell-friendly constructs that can be integrated with underlying bone, BIO INX is contributing to new possibilities in orthopedic repair. The work builds on promising preclinical studies where regenerated cartilage enabled mobility recovery in animal models. Through this line of development, the company aims to support therapies for joint degradation, spinal conditions, and other structural issues that impact millions worldwide. The road to clinical application is complex and highly regulated. Efforts like those of BIO INX represent a step toward a more seamless integration between research and patient care. Through its commitment to standardization, investment in enabling technologies, and involvement in proof-of-concept projects, the company continues to support the field's gradual shift from theory to therapy.
Yahoo
27-01-2025
- Health
- Yahoo
Biocompatible 3D Printing Materials Market Trends Analysis Report 2025-2030: Increasing Demand of Biocompatible 3D Printing Materials in Healthcare Settings
Biocompatible 3D Printing Materials Market Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "Biocompatible 3D Printing Materials Market Size, Share & Trends Analysis Report By Type, By Application, By Region, and Segment Forecasts, 2025 - 2030" report has been added to global biocompatible 3D printing materials market size was estimated at USD 664.7 million in 2024 and is projected to grow at a CAGR of 14.6% from 2025 to 2030 Advancements in 3D printing techniques, including developing specialized biocompatible materials, enable the creation of patient-specific devices with enhanced functionality and improved integration with the human body. In April 2024, a study in Biomedicines assessed the safety and feasibility of biocompatible 3D printing materials for intra-procedural guides in cardiac ablation. Prototypes showed good geometrical integrity post-sterilization, but traces of nitrogen and sulfur were found in some samples after ablation, indicating a need for additional clinical research. The healthcare industry is experiencing a rising demand for biocompatible materials used in medical applications such as implants, prosthetics, and tissue engineering. These materials are designed to be compatible with the human body, reducing the likelihood of rejection or negative reactions. This demand is driving the development of advanced biocompatible materials for 3D printing. In June 2024, BIO INX launched DEGRES INX, an innovative biodegradable resin with shape memory capabilities designed for DLP-based 3D-(bio)printing. This unique material can be deformed temporarily and returns to its original shape when heated to body temperature. Furthermore, it meets ISO biocompatibility standards, making it suitable for cell technological advancements in 3D printing have significantly influenced the market for biocompatible materials. Innovations in materials and printing processes have created safe and effective options for medical applications. In October 2024, VBN Components, a Swedish company, made significant advancements in wear-resistant additive manufacturing materials. Their Vibenite portfolio featured innovative alloys poised to replace cobalt chrome in medical implants due to increasing safety concerns associated with cobalt chrome rise of personalized medicine is further propelling the biocompatible 3D printing materials market. This approach focuses on providing customized treatments based on individual patient characteristics, such as genetic makeup and lifestyle choices. In the realm of 3D printing, personalized medicine facilitates the creation of tailored medical devices, implants, and pharmaceuticals specifically designed to address the unique needs of each patient. In October 2024, Boston Micro Fabrication (BMF) introduced four new materials for its microArch series 3D printers, specifically targeting the medical device sector. The HTF resin stands out for its high-temperature resistance, biocompatibility, and flexibility, making it ideal for medical applications where sterilization and material performance are Landscape of Key Players Formlabs Inc. 3D Systems Inc. Evonik Industries AG Stratasys Concept Laser Gmbh Renishaw plc ENVISIONTEC US LLC CELLINK DETAX Ettlingen Hoganas AB Key Attributes: Report Attribute Details No. of Pages 110 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $664.7 million Forecasted Market Value (USD) by 2030 $1480 million Compound Annual Growth Rate 14.6% Regions Covered Global Key Topics Covered: Chapter 1. Methodology and ScopeChapter 2. Executive Summary 2.1. Market Outlook2.2. Segment Outlook2.2.1. Type outlook2.2.2. Application outlook2.3. Competitive InsightsChapter 3. Biocompatible 3D Printing Materials Market Variables, Trends & Scope 3.1. Market Lineage Outlook3.1.1. Parent market outlook3.1.2. Related/ancillary market outlook3.2. Market Dynamics3.2.1. Market driver analysis3.2.1.1. Increasing demand of biocompatible 3D printing materials in healthcare industry3.2.1.2. Technological advancements in 3D printing materials3.2.1.3. Growing adoption of personalized medicine3.2.2. Market restraint analysis3.2.2.1. High cost of biocompatible 3D printing materials3.2.2.2. Regulatory hurdles3.3. Biocompatible 3D Printing Materials Market Analysis Tools3.3.1. Industry Analysis - Porter's3.3.2. PESTEL AnalysisChapter 4. Biocompatible 3D Printing Materials Market: Type Estimates & Trend Analysis 4.1. Global Biocompatible 3D Printing Materials Market: Type Dashboard4.2. Global Biocompatible 3D Printing Materials Market: Type Movement Analysis4.3. Global Biocompatible 3D Printing Materials Market by Type, Revenue4.4. Polymer4.4.1. Polymer market estimates and forecasts 2018 to 2030 (USD Billion)4.5. Metal4.6. OthersChapter 5. Biocompatible 3D Printing Materials Market: Application Estimates & Trend Analysis 5.1. Global Biocompatible 3D Printing Materials Market: Application Dashboard5.2. Global Biocompatible 3D Printing Materials Market: Application Movement Analysis5.3. Global Biocompatible 3D Printing Materials Market by Application, Revenue5.4. Implants & Prosthesis5.4.1. Implants & Prosthesis market estimates and forecasts 2018 to 2030 (USD Billion)5.5. Prototyping & Surgical Guides5.6. Tissue Engineering5.7. Hearing Aids5.8. OthersChapter 6. Biocompatible 3D Printing Materials Market: Regional Estimates & Trend Analysis by Country, Type, and Application 6.1. Regional Dashboard6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030Chapter 7. Competitive Landscape 7.1. Recent Developments & Impact Analysis, By Key Manufacturers7.2. Company/Competition Categorization7.3. Vendor Landscape7.3.1. List of key distributors and channel partners7.3.2. Key customers7.3.3. Key company market share analysis, 20247.4. Company Profiles7.4.1. Company overview7.4.2. Financial performance7.4.3. Product benchmarking7.4.4. Strategic initiatives For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Biocompatible 3D Printing Materials Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
